MIL:1GEHC (USA)
Â
Common Stock
€
59.66
(0%)
Jul 31
Business Description
GE HealthCare Technologies Inc
NAICS : 325413
SIC : 3844
ISIN : US36266G1076
Share Class Description:
MIL:1GEHC: Common StockTotal Employee Number:
54,000Compare
Compare
Traded in other countries / regions
GEHC.USAGEHC.Mexico1GEHC.ItalyL0T.GermanyGEHC34.Brazil IPO Date
2025-04-28Description
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 0.96 | |||||
Debt-to-EBITDA | 2.85 | |||||
Interest Coverage | 6.4 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.86 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.7 | |||||
3-Year EBITDA Growth Rate | 5.1 | |||||
3-Year EPS without NRI Growth Rate | -0.3 | |||||
3-Year FCF Growth Rate | -6.1 | |||||
3-Year Book Growth Rate | 3.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.46 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.93 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 66.68 | |||||
9-Day RSI | 65.2 | |||||
14-Day RSI | 62.67 | |||||
3-1 Month Momentum % | 11.33 | |||||
6-1 Month Momentum % | -16.19 | |||||
12-1 Month Momentum % | -13.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 0.97 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 66.17 | |||||
Days Sales Outstanding | 60.17 | |||||
Days Payable | 89.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.2 | |||||
Dividend Payout Ratio | 0.03 | |||||
Forward Dividend Yield % | 0.21 | |||||
5-Year Yield-on-Cost % | 0.2 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.37 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.53 | |||||
Operating Margin % | 12.85 | |||||
Net Margin % | 9.33 | |||||
EBITDA Margin % | 17.38 | |||||
FCF Margin % | 7.38 | |||||
OCF Margin % | 9.84 | |||||
ROE % | 19.18 | |||||
ROA % | 5.42 | |||||
ROIC % | 6.85 | |||||
3-Year ROIIC % | 2.85 | |||||
ROC (Joel Greenblatt) % | 100.91 | |||||
ROCE % | 11.26 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.6 | |||||
Forward PE Ratio | 14.08 | |||||
PE Ratio without NRI | 14.69 | |||||
Price-to-Owner-Earnings | 11.85 | |||||
PEG Ratio | 7.73 | |||||
PS Ratio | 1.46 | |||||
PB Ratio | 2.8 | |||||
Price-to-Free-Cash-Flow | 19.7 | |||||
Price-to-Operating-Cash-Flow | 14.8 | |||||
EV-to-EBIT | 12.76 | |||||
EV-to-Forward-EBIT | 11.82 | |||||
EV-to-EBITDA | 10.67 | |||||
EV-to-Forward-EBITDA | 10.06 | |||||
EV-to-Revenue | 1.85 | |||||
EV-to-Forward-Revenue | 1.8 | |||||
EV-to-FCF | 24.97 | |||||
Price-to-GF-Value | 0.81 | |||||
Earnings Yield (Greenblatt) % | 7.84 | |||||
FCF Yield % | 5.14 |
GE HealthCare Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GE HealthCare Technologies Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 08:30 | In 89 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 88 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-29 08:30 | 54.74 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-07-29 | 54.74 (+0.00%) | ||
| USD 0.035000 Cash Dividend | 2026-07-24 | 54.74 (+0.00%) | ||
| Jefferies Global Healthcare Conference | 2026-06-03 08:20 | 52.86 (+0.00%) | ||
| Guidance call for 2026 | 2026-05-12 13:40 | 52.01 (+0.00%) | ||
| General meeting for 2026 | 2026-05-07 08:00 | 52.01 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-29 08:30 | 59.32 (-2.80%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 59.32 (-2.80%) |
Show
Entries
Press Release
Articles on GE HealthCare Technologies Inc
No articles.